BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1326808)

  • 1. Mutation of the HANA protein of Sendai virus by passage in eggs.
    Itoh M; Wang XL; Suzuki Y; Homma M
    Virology; 1992 Sep; 190(1):356-64. PubMed ID: 1326808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity.
    Gorman WL; Gill DS; Scroggs RA; Portner A
    Virology; 1990 Mar; 175(1):211-21. PubMed ID: 1689918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin.
    Itoh M; Ming TD; Hayashi T; Mochizuki Y; Homma M
    J Virol; 1990 Nov; 64(11):5660-4. PubMed ID: 2170692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 1 affects its functional but not its antigenic properties.
    Gorman WL; Pridgen C; Portner A
    Virology; 1991 Jul; 183(1):83-90. PubMed ID: 1647078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid mutation at position 170 of human parainfluenza virus type 1 fusion glycoprotein induces obvious syncytium formation and caspase-3-dependent cell death.
    Takaguchi M; Takahashi T; Hosokawa C; Ueyama H; Fukushima K; Hayakawa T; Itoh K; Ikeda K; Suzuki T
    J Biochem; 2011 Feb; 149(2):191-202. PubMed ID: 21186250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in mice.
    Tashiro M; Seto JT; Choosakul S; Hegemann H; Klenk HD; Rott R
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1575-9. PubMed ID: 1339465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human parainfluenza virus type 1 evolution combines cocirculation of strains and development of geographically restricted lineages.
    Hetherington SV; Watson AS; Scroggs RA; Portner A
    J Infect Dis; 1994 Feb; 169(2):248-52. PubMed ID: 7508966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sendai (parainfluenza 1) infection of mouse eggs.
    Tuffrey M; Zisman B; Barnes RD
    Br J Exp Pathol; 1972 Dec; 53(6):638-40. PubMed ID: 4345810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
    Lu B; Zhou H; Ye D; Kemble G; Jin H
    J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains.
    Sakaguchi T; Kiyotani K; Sakaki M; Fujii Y; Yoshida T
    Arch Virol; 1994; 135(1-2):159-64. PubMed ID: 8198441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus.
    Wang XL; Itoh M; Hotta H; Homma M
    J Virol; 1994 May; 68(5):3369-73. PubMed ID: 8151795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Location of amino acid residues important for the structure and biological function of the haemagglutinin-neuraminidase glycoprotein of Sendai virus by analysis of escape mutants.
    Lyn D; Mazanec MB; Nedrud JG; Portner A
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():817-24. PubMed ID: 1849969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mutations associated with attenuation of virulence of a field Sendai virus isolate by egg passage.
    Fujii Y; Sakaguchi T; Kiyotani K; Huang C; Fukuhara N; Yoshida T
    Virus Genes; 2002 Oct; 25(2):189-93. PubMed ID: 12416681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants.
    Thompson SD; Portner A
    Virology; 1987 Sep; 160(1):1-8. PubMed ID: 2820122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein.
    Bousse T; Takimoto T
    J Virol; 2006 Sep; 80(18):9009-16. PubMed ID: 16940513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of amino acid positions associated with neuraminidase activity of the hemagglutinin-neuraminidase glycoprotein of Sendai virus.
    Gorman WL; Takahashi T; Scroggs RA; Portner A
    Virology; 1991 Feb; 180(2):803-8. PubMed ID: 1846501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allantoic fluid protease activity during influenza virus infection.
    Ewasyshyn ME; Sabina LR
    Acta Virol; 1986 Mar; 30(2):109-18. PubMed ID: 2873727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the leader sequence in Sendai virus pathogenesis revealed by recovery of a pathogenic field isolate from cDNA.
    Fujii Y; Sakaguchi T; Kiyotani K; Huang C; Fukuhara N; Egi Y; Yoshida T
    J Virol; 2002 Sep; 76(17):8540-7. PubMed ID: 12163573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some physico-chemical and biological properties of egg-Sendai virus with altered haemagglutinin-neuraminidase protein.
    Popa LM; Repanovici R; Iliescu R; Mihalache O; Cajal N
    Acta Virol; 1985 Dec; 29(6):461-5. PubMed ID: 2869656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sendai virus-induced cell fusion.
    Okada Y
    Methods Enzymol; 1993; 221():18-41. PubMed ID: 8395633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.